These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 15213583

  • 1. Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.
    Abikoff H, Hechtman L, Klein RG, Gallagher R, Fleiss K, Etcovitch J, Cousins L, Greenfield B, Martin D, Pollack S.
    J Am Acad Child Adolesc Psychiatry; 2004 Jul; 43(7):820-9. PubMed ID: 15213583
    [Abstract] [Full Text] [Related]

  • 2. Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.
    Hechtman L, Abikoff H, Klein RG, Weiss G, Respitz C, Kouri J, Blum C, Greenfield B, Etcovitch J, Fleiss K, Pollack S.
    J Am Acad Child Adolesc Psychiatry; 2004 Jul; 43(7):812-9. PubMed ID: 15213582
    [Abstract] [Full Text] [Related]

  • 3. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.
    Abikoff H, Hechtman L, Klein RG, Weiss G, Fleiss K, Etcovitch J, Cousins L, Greenfield B, Martin D, Pollack S.
    J Am Acad Child Adolesc Psychiatry; 2004 Jul; 43(7):802-11. PubMed ID: 15213581
    [Abstract] [Full Text] [Related]

  • 4. Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment: impact on parental practices.
    Hechtman L, Abikoff H, Klein RG, Greenfield B, Etcovitch J, Cousins L, Fleiss K, Weiss M, Pollack S.
    J Am Acad Child Adolesc Psychiatry; 2004 Jul; 43(7):830-8. PubMed ID: 15213584
    [Abstract] [Full Text] [Related]

  • 5. Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD.
    Klein RG, Abikoff H, Hechtman L, Weiss G.
    J Am Acad Child Adolesc Psychiatry; 2004 Jul; 43(7):792-801. PubMed ID: 15213580
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis.
    Van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM.
    Clin Psychol Rev; 2008 Jun; 28(5):783-800. PubMed ID: 18068284
    [Abstract] [Full Text] [Related]

  • 7. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C, Boidein F.
    Encephale; 2001 Jun; 27(5):435-43. PubMed ID: 11760693
    [Abstract] [Full Text] [Related]

  • 8. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM, Earls MF.
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [Abstract] [Full Text] [Related]

  • 9. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML, American Academy of Pediatrics Committee on Quality Improvement, American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [Abstract] [Full Text] [Related]

  • 10. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM.
    Clin Psychol Psychother; 2012 Jun; 19(3):270-8. PubMed ID: 21404369
    [Abstract] [Full Text] [Related]

  • 11. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P, Hsu HY, Chiou SS, Chao MC.
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
    Mohammadi MR, Kashani L, Akhondzadeh S, Izadian ES, Ohadinia S.
    J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
    [Abstract] [Full Text] [Related]

  • 13. Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings.
    Kolko DJ, Bukstein OG, Barron J.
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):578-86. PubMed ID: 10230190
    [Abstract] [Full Text] [Related]

  • 14. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 15. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 16. Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD.
    Pearson DA, Santos CW, Roache JD, Casat CD, Loveland KA, Lachar D, Lane DM, Faria LP, Cleveland LA.
    J Am Acad Child Adolesc Psychiatry; 2003 Feb; 42(2):209-16. PubMed ID: 12544181
    [Abstract] [Full Text] [Related]

  • 17. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
    Flapper BC, Schoemaker MM.
    Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
    [Abstract] [Full Text] [Related]

  • 18. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
    Pelham WE, Burrows-Maclean L, Gnagy EM, Fabiano GA, Coles EK, Tresco KE, Chacko A, Wymbs BT, Wienke AL, Walker KS, Hoffman MT.
    Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
    [Abstract] [Full Text] [Related]

  • 19. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, Civil R.
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
    Wigal S, Swanson JM, Feifel D, Sangal RB, Elia J, Casat CD, Zeldis JB, Conners CK.
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.